Cadian Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-110,000
Closed -$18.2M 43
2017
Q1
$18.2M Buy
+110,000
New +$17.5M 0.87% 32

Other funds holding ELV

Cadian Capital Management's ELV Position: Q2 2017 in Review

Cadian Capital Management sold out of Elevance Health (ELV) in Q2 2017, closing a stake of 110,000 shares — an estimated $18.2M sold.

Cadian Capital Management first reported a position in ELV in Q1 2017 and held it in 1 quarter. The position peaked at $18.2M in Q1 2017. 852 funds tracked by Wall St. Rank hold ELV as of Q2 2017.

  • Cadian Capital Management reported no remaining Elevance Health position as of Q2 2017 after selling out during the quarter.
  • Cadian Capital Management sold 110,000 Elevance Health shares in Q2 2017, an estimated $18.2M.
  • Cadian Capital Management first reported a position in Elevance Health in Q1 2017 and held it in 1 quarter.
  • Cadian Capital Management's Elevance Health position peaked at $18.2M in Q1 2017.
  • 852 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.

Based on Cadian Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.